Ruili Huang

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases
    David G Covell
    National Cancer Institute Frederick, Developmental Therapeutics Program, Screening Technologies Branch, Laboratory of Computational Technologies, Frederick, Maryland, USA
    Proteins 59:403-33. 2005
  2. ncbi request reprint Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen
    Ruili Huang
    Laboratory of Computational Technologies, Developmental Therapeutics Program, Screening Technologies Branch, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702, USA
    Genomics 87:315-28. 2006
  3. ncbi request reprint Evaluating chemical structure similarity as an indicator of cellular growth inhibition
    Anders Wallqvist
    National Cancer Institute, Developmental Therapeutics Program, Screening Technologies Branch, Frederick, Maryland 21702, USA
    J Chem Inf Model 46:430-7. 2006
  4. ncbi request reprint Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action
    Ruili Huang
    Developmental Therapeutics Program, Screening Technologies Branch, Laboratory of Computational Technologies, National Cancer Institute Frederick, Frederick, Maryland 21702, USA
    J Med Chem 49:1964-79. 2006
  5. ncbi request reprint Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data
    David G Covell
    National Cancer Institute Frederick, Developmental Therapeutics Program, Screening Technologies Branch, Laboratory of Computational Technologies, Frederick, MD 21702, USA
    Mol Cancer Ther 6:2261-70. 2007
  6. pmc Chemical genomics profiling of environmental chemical modulation of human nuclear receptors
    Ruili Huang
    National Institutes of Health Chemical Genomics Center, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 3370, USA
    Environ Health Perspect 119:1142-8. 2011
  7. pmc Weighted feature significance: a simple, interpretable model of compound toxicity based on the statistical enrichment of structural features
    Ruili Huang
    Department of Health and Human Services, NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    Toxicol Sci 112:385-93. 2009
  8. pmc Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening
    Ruili Huang
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    Chem Res Toxicol 21:659-67. 2008
  9. pmc Application of a homogenous membrane potential assay to assess mitochondrial function
    Srilatha Sakamuru
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    Physiol Genomics 44:495-503. 2012
  10. pmc Identification of small molecule compounds that inhibit the HIF-1 signaling pathway
    Menghang Xia
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892 3370, USA
    Mol Cancer 8:117. 2009

Collaborators

Detail Information

Publications44

  1. ncbi request reprint Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases
    David G Covell
    National Cancer Institute Frederick, Developmental Therapeutics Program, Screening Technologies Branch, Laboratory of Computational Technologies, Frederick, Maryland, USA
    Proteins 59:403-33. 2005
    ..e., few) molecular targets. Applications of data mining strategies that jointly utilize tumor cell screening, genomic, and structural data are presented for hypotheses generation and identifying novel anticancer candidates...
  2. ncbi request reprint Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen
    Ruili Huang
    Laboratory of Computational Technologies, Developmental Therapeutics Program, Screening Technologies Branch, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702, USA
    Genomics 87:315-28. 2006
    ..The knowledge of the nature of gene expression regulation and biological pathways can be applied to understanding the mechanism by which small drug molecules interfere with biological systems...
  3. ncbi request reprint Evaluating chemical structure similarity as an indicator of cellular growth inhibition
    Anders Wallqvist
    National Cancer Institute, Developmental Therapeutics Program, Screening Technologies Branch, Frederick, Maryland 21702, USA
    J Chem Inf Model 46:430-7. 2006
    ..Structurally and functionally similar compounds can have distinguishable biological responses reflecting different mechanisms of action...
  4. ncbi request reprint Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action
    Ruili Huang
    Developmental Therapeutics Program, Screening Technologies Branch, Laboratory of Computational Technologies, National Cancer Institute Frederick, Frederick, Maryland 21702, USA
    J Med Chem 49:1964-79. 2006
    ..Finally, we offer a strategy to exploit this relationship for future mining of novel anticancer candidates...
  5. ncbi request reprint Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data
    David G Covell
    National Cancer Institute Frederick, Developmental Therapeutics Program, Screening Technologies Branch, Laboratory of Computational Technologies, Frederick, MD 21702, USA
    Mol Cancer Ther 6:2261-70. 2007
    ..These results are extended to applications of two-dimensional structural features to further refine compound selections based on tumor panel sensitivity obtained from tumor screening results...
  6. pmc Chemical genomics profiling of environmental chemical modulation of human nuclear receptors
    Ruili Huang
    National Institutes of Health Chemical Genomics Center, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 3370, USA
    Environ Health Perspect 119:1142-8. 2011
    ....
  7. pmc Weighted feature significance: a simple, interpretable model of compound toxicity based on the statistical enrichment of structural features
    Ruili Huang
    Department of Health and Human Services, NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    Toxicol Sci 112:385-93. 2009
    ..The new algorithm has the important advantages of simplicity, power, interpretability, and ease of implementation...
  8. pmc Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening
    Ruili Huang
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    Chem Res Toxicol 21:659-67. 2008
    ..The performance of this clustering method is evaluated by comparing the clustering results against literature annotations of compound mechanisms...
  9. pmc Application of a homogenous membrane potential assay to assess mitochondrial function
    Srilatha Sakamuru
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    Physiol Genomics 44:495-503. 2012
    ..Our results demonstrate that this homogenous cell-based Mito-MPS assay can be used to evaluate the ability of large numbers of chemicals to decrease mitochondrial function...
  10. pmc Identification of small molecule compounds that inhibit the HIF-1 signaling pathway
    Menghang Xia
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892 3370, USA
    Mol Cancer 8:117. 2009
    ..To identify small molecule inhibitors of the HIF-1 pathway, we have developed a cell-based reporter gene assay and screened a large compound library by using a quantitative high-throughput screening (qHTS) approach...
  11. pmc Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets
    Jing Yuan
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Science 333:724-9. 2011
    ..Drugs whose responses mapped to wild-type or mutant pfcrt alleles were tested in combination in vitro and in vivo, which yielded promising new leads for antimalarial treatments...
  12. pmc Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels
    Menghang Xia
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892 3370, USA
    Toxicol Appl Pharmacol 252:250-8. 2011
    ..Profiling environmental compound libraries for hERG channel inhibition provides information useful in prioritizing these compounds for cardiotoxicity assessment in vivo...
  13. pmc Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach
    Sunita J Shukla
    NIH Chemical Genomics Center, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, USA
    Environ Health Perspect 120:1150-6. 2012
    ..Thus, assays that detect the up-regulation of this pathway could be useful for identifying chemicals that induce oxidative stress...
  14. pmc Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors
    Amanda P Skoumbourdis
    NIH Chemical Genomics Center, National Human Genome Research Institute, NIH 9800 Medical Center Drive, MSC 3370 Bethesda, MD 20892 3370, USA
    Bioorg Med Chem Lett 19:3686-92. 2009
    ..Finally, docking studies with selective ligands (including 10 and 18) were undertaken to better understand this chemotypes ability to bind and inhibit PDE4 selectively...
  15. pmc Identification of compounds that potentiate CREB signaling as possible enhancers of long-term memory
    Menghang Xia
    NIH Chemical Genomics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 106:2412-7. 2009
    ..qHTS followed by interrogation of pathway targets is an efficient paradigm for lead generation for chemical genomics and drug development...
  16. pmc Compound cytotoxicity profiling using quantitative high-throughput screening
    Menghang Xia
    NIH Chemical Genomics Center, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 3370, USA
    Environ Health Perspect 116:284-91. 2008
    ..Such methods can be relatively expensive, low-throughput, and associated with pain suffered by the treated animals. In addition, differences in species biology may confound extrapolation to human health effects...
  17. pmc The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics
    Ruili Huang
    National Institutes of Health Chemical Genomics Center, NIH, Bethesda, MD 20892, USA
    Sci Transl Med 3:80ps16. 2011
    ..We report here the creation of a definitive, complete, and nonredundant list of all approved molecular entities as a freely available electronic resource and a physical collection of small molecules amenable to high-throughput screening...
  18. pmc Identification of chemical compounds that induce HIF-1alpha activity
    Menghang Xia
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892, USA
    Toxicol Sci 112:153-63. 2009
    ..Identification of environmental compounds having HIF-1alpha activation activity in cell-based assays may be useful for prioritizing chemicals for further testing as hypoxia-response inducers in vivo...
  19. pmc A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker
    Ming Hsuang Cho
    NIH Chemical Genomics Center, National Institutes of Health, 9800 Medical Center Drive, MSC 3370, Bethesda, MD 20892 3370, USA
    Toxicol In Vitro 22:1099-106. 2008
    ..This cytotoxicity assay, combined with the qHTS platform, allowed us to quickly and efficiently evaluate compound toxicities related to cell membrane integrity...
  20. pmc The Tox21 robotic platform for the assessment of environmental chemicals - from vision to reality
    Matias S Attene-Ramos
    NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA
    Drug Discov Today 18:716-23. 2013
    ..In this article, we describe the Tox21 screening process, compound library preparation, data processing, and robotic system validation. ..
  21. pmc Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1α inhibitors
    Wenwei Huang
    NIH Chemical Genomics Center, National Human Genome Research Institute, NIH, 9800 Medical Center Dr, Rockville, MD 20850, USA
    Bioorg Med Chem Lett 21:5239-43. 2011
    ..In this Letter, we describe an efficient one-pot sequential reaction for the synthesis of quinazolin-4-one 1 analogues. The structure-activity relationship (SAR) study led to the 5-fold more potent analogue, 16...
  22. pmc Identification of clinically used drugs that activate pregnane X receptors
    Sunita J Shukla
    National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
    Drug Metab Dispos 39:151-9. 2011
    ....
  23. pmc Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action
    Susanne C Miller
    NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biochem Pharmacol 79:1272-80. 2010
    ..Comprehensive profiling of approved drugs provides insight into their molecular mechanisms, thus providing a basis for drug repurposing...
  24. doi request reprint Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screening
    Matias S Attene-Ramos
    National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States
    Chem Res Toxicol 26:1323-32. 2013
    ..This comprehensive approach allows for the evaluation of thousands of environmental chemicals for mitochondrial toxicity and identification of possible MOAs. ..
  25. pmc A class of tricyclic compounds blocking malaria parasite oocyst development and transmission
    Richard T Eastman
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    Antimicrob Agents Chemother 57:425-35. 2013
    ..Further clinical evaluation of ketotifen and related compounds, including synthetic new derivatives, in blocking malaria transmission may provide new weapons for the current effort of malaria eradication...
  26. pmc High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death
    Jennifer T Fox
    Genome Instability Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 109:5423-8. 2012
    ..Furthermore, resveratrol and genistein killed multidrug-resistant cancer cells. We therefore propose that resveratrol, genistein, and baicalein are attractive candidates for improved chemotherapeutic agents...
  27. pmc Identification of a potent new chemotype for the selective inhibition of PDE4
    Amanda P Skoumbourdis
    NIH Chemical Genomics Center, National Human Genome Research Institute, NIH, 9800 Medical Center Drive, MSC 3370, Bethesda, MD 20892 3370, USA
    Bioorg Med Chem Lett 18:1297-303. 2008
    ..Synthesis, structure-activity relationships, and the selectivity of a highly potent analogue against related phosphodiesterase isoforms are presented...
  28. pmc The pilot phase of the NIH Chemical Genomics Center
    Craig J Thomas
    NIH Chemical Genomics Center, NHGRI, National Institutes of Health, 9800 Medical Center Drive, Building B, Room 3005, MSC 3370, Bethesda, MD 20892 3370, USA
    Curr Top Med Chem 9:1181-93. 2009
    ....
  29. pmc Inhibition of morphine-induced cAMP overshoot: a cell-based assay model in a high-throughput format
    Menghang Xia
    NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cell Mol Neurobiol 31:901-7. 2011
    ..The qHTS approach we used in this study will be useful in identifying novel inhibitors of morphine induced addiction from a larger scale screening...
  30. pmc Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening data
    Hongmao Sun
    National Institutes of Health, Chemical Genomics Center, NIH, Bethesda, Maryland 20892, United States
    J Chem Inf Model 51:2474-81. 2011
    ..These models can be useful in prioritizing compounds in a drug discovery pipeline or recognizing the toxic potential of environmental chemicals...
  31. pmc Phosphodiesterase 4 inhibitors enhance sexual pleasure-seeking activity in rodents
    Peixiong Yuan
    Biomarker Laboratory, National Institute of Mental Health, Mood and Anxiety Disorders Program, National Institutes of Health, Bethesda, MD 20892, USA
    Pharmacol Biochem Behav 98:349-55. 2011
    ..The results suggest that PDE4 may be a plausible contributor to the sexual pleasure-seeking deficits seen in depressed patients; inhibiting PDE4 may restore these deficits...
  32. pmc A quantitative high-throughput screen for modulators of IL-6 signaling: a model for interrogating biological networks using chemical libraries
    Ronald L Johnson
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892, USA
    Mol Biosyst 5:1039-50. 2009
    ..Small molecules within these series will make useful tool compounds to investigate IL-6 signaling mediated by JAK-STAT activation...
  33. pmc A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel
    Steven A Titus
    NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anal Biochem 394:30-8. 2009
    ..Our findings indicate that this thallium flux assay can be used as an alternative method to profile large-volume compound libraries for compound activity on the hERG channel...
  34. pmc A quantitative high-throughput screen identifies novel inhibitors of the interaction of thyroid receptor beta with a peptide of steroid receptor coactivator 2
    Ronald L Johnson
    NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
    J Biomol Screen 16:618-27. 2011
    ..Selected compounds were tested as independent samples, and a methylsulfonylnitrobenzoate series inhibited the TRβ-SRC2 interaction with 5 µM IC(50). This series represents a new class of thyroid hormone receptor-coactivator modulators...
  35. pmc Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries
    Henrike Veith
    NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland, USA
    Nat Biotechnol 27:1050-5. 2009
    ..We also identified chemical substructures that differentiated between the five isozymes. The pharmacological compendium described here should further the understanding of CYP isozymes...
  36. pmc Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum
    Jing Yuan
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    Nat Chem Biol 5:765-71. 2009
    ..This study identifies new leads for antimalarial drugs and demonstrates the utility of a high-throughput chemical genomic strategy for studying malaria traits...
  37. pmc Paradigm shift in toxicity testing and modeling
    Hongmao Sun
    Department of Health and Human Services, NIH Chemical Genomics Center, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    AAPS J 14:473-80. 2012
    ..It is perceivable that new in silico toxicity models based on high-quality qHTS data will achieve unprecedented reliability and robustness, thus becoming a valuable tool for risk assessment and drug discovery...
  38. pmc The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform
    Sunita J Shukla
    NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892 3370, USA
    Drug Discov Today 15:997-1007. 2010
    ..Here, we describe the Tox21 collaboration, qHTS-based compound testing and the various Tox21 screening assays that have been validated and tested at the NCGC to date...
  39. pmc An image-based, high-throughput screening assay for molecules that induce excess DNA replication in human cancer cells
    Wenge Zhu
    National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892 2753, USA
    Mol Cancer Res 9:294-310. 2011
    ..Thus, this assay provides a new approach to the discovery of compounds useful for investigating the regulation of genome duplication and for the treatment of cancer...
  40. pmc Dose-response modeling of high-throughput screening data
    Fred Parham
    National Institutes of Health NIH National Institute of Environmental Health Sciences NIEHS, Research Triangle Park, North Carolina 27709, USA
    J Biomol Screen 14:1216-27. 2009
    ..Various statistical tests for identifying significant concentration-response relationships and for addressing reproducibility are developed and presented...
  41. doi request reprint Fluorescence spectroscopic profiling of compound libraries
    Anton Simeonov
    NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892 3370, USA
    J Med Chem 51:2363-71. 2008
    ..Native compound fluorescence, fluorescent impurities, novel fluorescent compounds, and the utilization of fluorescence profiling data are discussed...
  42. pmc A grid algorithm for high throughput fitting of dose-response curve data
    Yuhong Wang
    National Institutes of Health, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, MD 20850, USA
    Curr Chem Genomics 4:57-66. 2010
    ....
  43. pmc Two High Throughput Screen Assays for Measurement of TNF-α in THP-1 Cells
    Kristin P Leister
    NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Curr Chem Genomics 5:21-9. 2011
    ..We also identified several novel inhibitors of TNF-α, such as BTO-1, CCG-2046, ellipticine, and PD 169316. The results demonstrated that both homogeneous TNF-α assays are robust and suitable for high throughput screening...
  44. ncbi request reprint Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells
    Anders Wallqvist
    Science Applications International Corp, National Cancer Institute, NIH, Bethesda, MD, USA
    Mol Cancer Ther 4:1559-68. 2005
    ..We suggest that compounds identified in this study may represent new classes of potential anticancer agents...